+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tak 003"

Travel Vaccines Global Market Report 2024 - Product Thumbnail Image

Travel Vaccines Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Disease Analysis: Dengue Vaccines - Product Thumbnail Image

Disease Analysis: Dengue Vaccines

  • Report
  • March 2021
  • 40 Pages
  • Global
Drug Overview: TAK-003 - Product Thumbnail Image

Drug Overview: TAK-003

  • Drug Pipelines
  • January 2018
  • 18 Pages
  • Global
From
Drug Overview: TetraVax-DV - Product Thumbnail Image

Drug Overview: TetraVax-DV

  • Drug Pipelines
  • January 2018
  • 16 Pages
  • Global
From
Drug Overview: DPIV - Product Thumbnail Image

Drug Overview: DPIV

  • Drug Pipelines
  • January 2018
  • 13 Pages
  • Global
From
Disease Overview: Dengue Vaccines - Product Thumbnail Image

Disease Overview: Dengue Vaccines

  • Drug Pipelines
  • January 2018
  • 83 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Tak 003 market is a segment of the global vaccine industry that focuses on the development and production of vaccines for infectious diseases. It is a rapidly growing market, driven by the need to protect populations from the threat of emerging and re-emerging diseases. Vaccines developed in the Tak 003 market are designed to be safe, effective, and affordable, and are used to protect people of all ages from a variety of infectious diseases. The Tak 003 market is composed of a variety of companies, including pharmaceutical companies, biotechnology companies, and vaccine manufacturers. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. These companies are involved in the research, development, and production of vaccines for a variety of infectious diseases. Show Less Read more